2024 Trends for Life Sciences Operations
The life sciences industry is at the cusp of a transformation, with technology playing a pivotal role in driving innovation. Operational efficiency isn't just a buzzword – it's a necessity for sustainable success. And Pharma in the MENA region is no exception.
As we step into 2024, we explore the key trends shaping the operational landscape of MENA life sciences companies, focusing on adapting to changing regulations, embracing digital transformation, enhancing employee efficiency, and optimizing processes.?
Here are some things we are looking at:
Check out the full article on the website.
In other news, we are excited to announce two new customers.
The first is Amman Pharmaceutical Industries. Amman Pharma is implementing Scigeniq DMS and RMS.
领英推荐
“Partnering with Scigeniq and implementing their DMS and RMS solutions is part of our ongoing investments in systems and digitization. Their strong industry expertise complements our own and their innovative technology platforms will surely enable our continued rapid growth within the MENA pharmaceutical market,” said Ismail Alatrash, Deputy GM of Amman Pharma.
The second is Cooper Pharmaceutical. Cooper Pharma is implementing Scigeniq RMS. With their internal launch of Scigeniq RMS, Cooper Pharma will benefit from an? extensive set of capabilities, including:
"We realized that addressing regulatory requirements across the regions in which we operate was taking more and more time and resources, and wanted a way to streamline those activities. And we selected Scigeniq's RMS not just for its capabilities, but because of their position as a leading software vendor for pharma companies in the MENA region," said Ayman Cheikh-Lahlou, CEO of Cooper Pharma.
That's it for this 2023. We hope you have enjoyed this newsletter. Please share it with your colleagues. And we'll see you in 2024.